Catalyst Pharmaceuticals Inc (CPRX)
16.50
+0.10
(+0.61%)
USD |
NASDAQ |
May 17, 16:00
16.74
+0.24
(+1.45%)
After-Hours: 20:00
Catalyst Pharmaceuticals Net Income (Annual): 71.41M for Dec. 31, 2023
Net Income (Annual) Chart
Historical Net Income (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 71.41M |
| December 31, 2022 | 83.08M |
| December 31, 2021 | 39.48M |
| December 31, 2020 | 74.98M |
| December 31, 2019 | 31.88M |
| December 31, 2018 | -34.00M |
| December 31, 2017 | -18.41M |
| December 31, 2016 | -18.07M |
| December 31, 2015 | -20.23M |
| December 31, 2014 | -15.51M |
| December 31, 2013 | -12.15M |
| Date | Value |
|---|---|
| December 31, 2012 | -4.076M |
| December 31, 2011 | -6.391M |
| December 31, 2010 | -4.006M |
| December 31, 2009 | -7.242M |
| December 31, 2008 | -10.56M |
| December 31, 2007 | -4.140M |
| December 31, 2006 | -2.730M |
| December 31, 2005 | -1.805M |
| December 31, 2004 | -0.5398M |
| December 31, 2003 | -0.4286M |
| December 31, 2002 | -0.2559M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Annual) Range, Past 5 Years
31.88M
Minimum
2019
83.08M
Maximum
2022
60.17M
Average
71.41M
Median
2023
Net Income (Annual) Benchmarks
| Pfizer Inc | 2.119B |
| Sarepta Therapeutics Inc | -535.98M |
| PTC Therapeutics Inc | -626.60M |
| Corcept Therapeutics Inc | 106.14M |
| Cytokinetics Inc | -526.24M |